Neoantigen Discovery: Realizing the Promise of Personalized Treatment

Originally Aired April 18, 2019

Advances in next-generation sequencing technology and computational data analysis have revolutionized efforts to identify tumor-specific mutant antigens. These altered, potentially immunogenic proteins may prove to be an important target for immunotherapies. In this Cell Press Webinar, Nicholas McGranahan (University College London) and Gerald Linette (University of Pennsylvania) will review progress made and future applications of this important area of cancer immunogenomics.

Nicholas McGranahan
Group Leader, Cancer Genome Evolution Research Group
University College London
View Biography
Gerald P. Linette
Parker Institute for Cancer Immunotherapy
Center for Cellular Immunotherapies
Perelman School of Medicine
University of Pennsylvania
View Biography
Moderator: Jiaying Tan
Senior Scientific Editor

Registration Details:

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

(*) denotes required form field(s)